Business ❯Pharmaceutical Industry

Drug Manufacturing

Pricing Strategies Novo Nordisk Market Competition Investment Quality Control Supply Chain Issues Regulatory Compliance Compounding Pharmacies Purdue Pharma Eli Lilly and Co.

Delhi High Court Directs DCGI to Reassess Weight-Loss Drug Approvals Within Three Months

The court’s three-month deadline for a reasoned ruling aims to close regulatory gaps in off-label obesity treatments

Delhi High Court Bars Dr. Reddy’s and OneSource from Marketing Semaglutide

Wall Street Journal Denounces Trump's Medicaid Drug Pricing Plan

Sanofi Finalizes €10 Billion Sale of Opella to U.S. Fund CD&R

Federal Judge Upholds FDA Ban on Compounded Ozempic and Wegovy Copies

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

India Halts Aveo Pharmaceuticals Over Illegal Opioid Exports to West Africa

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Hurricane Helene Disrupts IV Fluid Supply, Delaying Surgeries Nationwide

Massive Cocaine Seizure in Gujarat Uncovers International Drug Network

Pioneers of Obesity Drugs Win Prestigious Lasker Award

FDA Faces Backlog of 2,000 Uninspected Drug Plants Post-COVID

Jury Finds Zantac Not Responsible for Illinois Woman's Colon Cancer

Pharmacy Owner Pleads No Contest in Meningitis Outbreak Case

Novo Nordisk Expands Production Capacity with $16.5 Billion Catalent Acquisition

Western Pharma Companies Pivot to India Amid China Concerns